Shaanxi Micot Pharmaceutical Technology Co., Ltd.

This study is testing whether an experimental drug called MT200605 can help people recover better after a stroke. It aims to protect brain cells and reduce damage. The trial will enroll 360 stroke patients across China who will receive either the drug or a placebo along with stan…

This study is testing a new drug called MT1013 to see if it works as well or better than the standard medication (cinacalcet) for controlling high parathyroid hormone levels in people on long-term dialysis. About 424 adult patients will be randomly assigned to take either the new…

This early-stage study aims to understand how the body processes and eliminates a new experimental drug called MT1013. It will involve 6 adults with a specific bone and mineral disorder related to kidney failure who are on regular dialysis. The main goal is to track where the dru…